SavedAdd your journal

Journals / Laparoscopic Endoscopic Surgical Science / 2018 / Cilt: 25 - Sayı: 4

Pancreatitis Due to the Total Displacement of Intragastric Balloon to Duodenu

Birol AĞCA
Nuriye Esen BULUT
Yalın İŞCAN
Kemal MEMİŞOĞLU
Pages
157–160
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thirteen cases of pancreatatitis due to IGB administration have been reported so far.In this study, a patient with morbid obese patient, acute abdominal pain and vomiting, who had intragastric balloon application five months ago, was evaluated.Biochemical and radiological work-up revealed total migration of the balloon to duodenum and acute pancreatitis due to compression effect.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Intragastric balloon (IGB) application in obesity treatment is an easily applied non-surgical method which has an effective weight loss potential.
📊
Key Findings & Data:However, with increasing use in recent years, life-threatening complications have been reported in the literature.
💡
Conclusion & Impact:Thirteen cases of pancreatatitis due to IGB administration have been reported so far.In this study, a patient with morbid obese patient, acute abdominal pain and vomiting, who had intragastric balloon application five months ago, was evaluated.Biochemical and radiological work-up revealed total migration of the balloon to duodenum and acute pancreatitis due to compression effect.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Intragastric balloon (IGB) application in obesity treatment is an easily applied non-surgical method which has an effective weight loss potential. However, with increasing use in recent years, life-threatening complications have been reported in the literature. In addition to gastric perforation and intestinal obstruction due to serious complications, it has recently started to take its place in the literature. Thirteen cases of pancreatatitis due to IGB administration have been reported so far.In this study, a patient with morbid obese patient, acute abdominal pain and vomiting, who had intragastric balloon application five months ago, was evaluated.Biochemical and radiological work-up revealed total migration of the balloon to duodenum and acute pancreatitis due to compression effect.

🔖

Cite This Article

AĞCA, B., BULUT, N. E., İŞCAN, Y., MEMİŞOĞLU, K. (2018). Pancreatitis Due to the Total Displacement of Intragastric Balloon to Duodenu. Laparoscopic Endoscopic Surgical Science, Cilt: 25 - Sayı: 4, 157–160. https://ajindex.com/articles/345173

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Aljiffry M, Habib R, Kotbi E, Ageel A, Hassanain M, Dahlan Y. Acute Pancreatitis: A Complication of Intragastric Balloon. Surg Laparosc Endosc Percutan Tech 2017;27:456–9.
  2. Tate CM, Geliebter A. Intragastric Balloon Treatment for Obesity: Review of Recent Studies. Adv Ther 2017;34:1859–75. Hamilton A. Metabolic and bariatric surgery: American Society for Metabolic and Bariatric Surgery. 2013. https://asmbs. org/app/uploads/2014/05/Metabolic+Bariatric-Surgery.pdf. Phillips RJ1, Powley TL. Gastric volume rather than nutrient content inhibits food intake. Am J Physiol 1996;271(3 Pt 2):R766–9. Imaz I, Martínez-Cervell C, García-Alvarez EE, Sendra-Gutiérrez JM, González Enríquez J. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg 2008;18:841–6. Mathus-Vliegen EM1, Tytgat GN. Intragastric balloons for morbid obesity: results, patient tolerance and balloon life span. Br J Surg 1990;77:76–9.
  3. Mohammed AE, Benmousa A. Acute pancreatitis complicating intragastric balloon insertion. Case Rep Gastroenterol 2008;2:291–5.
  4. Gore N, Ravindran P, Chan DL, Das K, Cosman PH. Pancreatitis from intra gastric balloon insertion: Case report and literature review. Int J Surg Case Rep 2018;45:79–82. ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, Sullivan S, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 2015;82:425–38.e5. Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 2005;61:19–27.
  5. Ganesh R, Rao AD, Baladas HG, Leese T. The Bioenteric Intragastric Balloon (BIB) as a treatment for obesity: poor results in Asian patients. Singapore Med J 2007;48:227–31.
  6. Geliebter A, Westreich S, Gage D. Gastric distention by balloon and test-meal intake in obese and lean subjects. Am J Clin Nutr 1988;48:592–4. Geliebter A. Gastric distension and gastric capacity in relation to food intake in humans. Physiol Behav 1988;44:665–8.
  7. Öztürk A, Yavuz Y, Atalay T. A Case of Duodenal Obstruction and Pancreatitis Due to Intragastric Balloon. Balkan Med J 2015;32:323–6.